173656
Moving heart disease prevention and health promotion into effective public policy
Tuesday, October 28, 2008
Kathryn Guccione, MA
,
Associate Director of Public Policy & PR, Women In Government, Washington, DC
Women In Government (WIG) engages state legislators nationwide in policy and awareness efforts to help reduce cardiovascular disease through coordinated state legislative action. This presentation will disseminate policy recommendations from WIG's Women and Heart Disease State Legislative Task Force, a bipartisan coalition of state legislators working to reduce the impact of cardiovascular disease on women and their families through promoting awareness, implementing prevention and early intervention strategies based on established medical guidelines, facilitating partnerships, sharing best practices and developing a state action plan. The success of WIG's Medicare Preventive Services Policy Resource Center will validate its strategy to successfully spur similar legislative action in the area of cardiovascular disease prevention and its place in informing public health policy. For example, WIG was instrumental in the role of policymakers introducing and enacting bills and resolutions targeting cervical cancer prevention in all 50 states.
Learning Objectives: Identify the causes of cardiovascular disease and define opportunities for awareness and prevention.
Discuss and support key legislative policy recommendations.
Identify key public health partnerships to increase chronic disease prevention.
Evaluate existing prevention and awareness programs, including the introduction and implementation of heart disease prevention programs, task forces and policies; and employ strategies for the enhancement of these programs and policies.
Keywords: Public Health Policy, Heart Disease
Presenting author's disclosure statement:Qualified on the content I am responsible for because: Sarah Wells is the Vice President of Women In Government and has presented oral and poster sessions at APHA on several occassions. In this position, she assists the President and Board of Directors with strategic planning, special projects, the development of international programming and the facilitation of conferences and events. Furthermore, Sarah directs the Public Policy, Operations and Development Departments.
Sarah received her Master’s Degree in Public Policy from The George Washington University and Bachelors Degree in Political Science and Women’s Studies from the American University. In addition, she received a certificate in executive nonprofit leadership and completed coursework in clinical vaccine trials and good clinical practice at Johns Hopkins University.
Sarah is an appointed member from the Mason District on the Fairfax County, Virginia Advisory Social Services Board. She is also a member of the American University Government Relations Alumni Career Committee and is a National Honorary Committee Member of the Collegiate Cancer Council. Furthermore, Sarah is a past member and Fundraising Committee Chair for the Board of Directors of Community Bridges, a nonprofit organization in the Washington DC-area. Sarah has written for a wide variety of publications including the American Public Health Association and a forthcoming article in the Journal of the Academy for Medical-Surgical Nursing. She frequently speaks before national audiences including the annual Unite for Sight Conference at Stanford and Yale, before graduate classes at the Johns Hopkins University and Trinity College and internationally for the Pan American Health Organization and United Nations Educational, Scientific and Cultural Organization.
Before joining Women In Government in 1999, Sarah was employed with the Tioga County Legislature in New York State. In that capacity, she worked on a variety of outreach programs in conjunction with the County Economic Development and Information Technology Departments and with the Cornell University Cooperative Extension team.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines,
and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed
in my presentation.
|